Yee, D
, Haddad, T, Albain, K, Barker, A, Benz, C
, Boughey, J, Buxton, M, Chien, AJ, DeMichele, A, Dilts, D, Elias, A, Haluska, P, Hogarth, M, Hu, A, Hytlon, N, Kaplan, HG, Kelloff, GG, Khan, Q, Lang, J, Leyland-Jones, B
, Liu, M, Nanda, R
, Northfelt, D, Olopade, OI, Park, J, Parker, B, Parkinson, D, Pearson-White, S, Perlmutter, J, Pusztai, L, Symmans, F, Rugo, H, Tripathy, D, Wallace, A, Wholley, D, Van't Veer, L, Berry, DA & Esserman, L 2012, '
Adaptive trials in the neoadjuvant setting: A model to safely tailor care while accelerating drug development',
Journal of Clinical Oncology, vol. 30, no. 36, pp. 4584-4586.
https://doi.org/10.1200/JCO.2012.44.1022